The Asia-Pacific varicose vein treatment market was worth USD 70.33 million in 2023. The Asia-Pacific market is further expected to grow at a CAGR of 6.9% from 2024 to 2032 and be worth USD 128.22 million by 2032 from USD 75.18 million in 2024.
The rising prevalence of varicose veins in the Asia-Pacific is primarily propelling the varicose vein treatment market growth in this region. This condition of enlarged veins appears mostly in the feet and legs. It can be caused by pregnancy, hormonal changes, genetic disorders, and high blood pressure. The Asia-Pacific varicose vein treatment market is further anticipated to witness impressive growth in the near future due to the surge in disposable income, improvement in healthcare infrastructure, increased patient awareness about the advantage of seeking early treatment, and rapid growth in the aging population.
However, the lack of trained vascular surgeons and expensive varicose vein treatment procedures can hinder the growth of this market.
Companies that are playing a prominent role in the Asia Pacific Varicose Vein Treatment Market profiled in the report are Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), Merz Aesthetics (U.S.).
This research report segmented and sub-segmented the Asia-Pacific Varicose Vein Treatment Market into the following categories.
By Treatment Type
By Device
By End-User
By Country
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region